Read Time:41 Second
Raipur, September 27, 2008: President Pratibha Patil is arriving here tomorrow on a two day tour of Chhattisgarh.
This would be her maiden visit of the state after becoming President.
The President would be arriving here at 4.20 PM and spent the night at Raj Bhawan here.
The next day she is scheduled to visit famous waterfall Chitrakoot, about 40 km from the district headquarters of Bastar.
On Monday Patil would participate in the Golden Jubilee function of the Dudhadhari Bajrang Government Women’s College at Raipur after which she would return back to New Delhi, officials said.
More Stories
Olympic Medalist Manu Bhaker New Brand Ambassador for Ministry of Ports, Shipping
The Double Olympic Medal Winner in Shooting Manu Bhaker was today appointed as the Brand Ambassador for the Ministry of Ports, Shipping & Waterways.
Centre advises Edible Oil Associations to maintain MRP of oil
Amid increase in prices of edible oil, Centre today advised the leading Edible Oil Associations to ensure that the MRP of each oil is maintained till the availability of edible oil stocks imported at 0 % & 12.5% Basic Customs Duty (BCD) and take up the issue with their members immediately.
Amit Shah chairs National Security Strategies Conference – 2024
Union Home and Cooperation Minister Amit Shah here today chaired the second day of the two-day National Security Strategies Conference – 2024.
Nominations open for Rashtriya Bal Puraskar 2024
The central government has invited nominations for the Pradhan Mantri Rashtriya Bal Puraskar till September 15, 2024.
Tripura’s NLFT and ATTF agree to shun violence, surrender arms, disband their armed organizations
A Memorandum of Settlement was signed here today, in the presence of Union Home Minister Amit Shah, between Government of India, Government of Tripura and National Liberation Front of Tripura (NLFT) and All Tripura Tiger Force (ATTF).
New heat-based approach to cancer treatment can reduce chemotherapy doses
Researchers have used a combination of ultra-small magnetic nanoparticles (MDs) along with a heat shock protein 90 inhibitor (HSP90i) at suboptimal doses for effective magnetic hyperthermia-based cancer therapy.